S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

MRK Merck and Co Inc

93.01

0.45 (0.49%)

Last Updated: 13:38:03

Delayed by 15 minutes

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

Both Shuttle Pharmaceuticals (Nasdaq:SHPH) and Northwest Biotherapeutics

To read the full story on AllPennyStocks.com, click here.

Merck (NYSE:MRK)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Merck Charts.

Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Merck Charts.

Merck and Co Inc News

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK
Monday 3 March 2025 (2 days ago) • PR Newswire (US)

Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
Thursday 27 February 2025 (6 days ago) • PR Newswire (US)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 25 February 2025 (1 week ago) • Edgar (US Regulatory)

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Tuesday 25 February 2025 (1 week ago) • Business Wire

Merck to Participate in the TD Cowen 45th Annual Health Care Conference
Monday 24 February 2025 (1 week ago) • Business Wire

The Gross Law Firm Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK
Monday 24 February 2025 (1 week ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Merck & Co., Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - MRK
Thursday 20 February 2025 (2 weeks ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
Tuesday 18 February 2025 (2 weeks ago) • Business Wire

Form 13F-HR - Quarterly report filed by institutional managers, Holdings
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 13 February 2025 (3 weeks ago) • Edgar (US Regulatory)

More Merck and Co Inc News Articles

Bell Buckle (PK)

Accredited Solutions (PK)

Impact Fusion (PK)

Good Vibrations Shoes (PK)

NioCorp Developments

Voip Pal Com (QB)

RespireRx Pharmaceuticals (CE)

Adia Nutrition (PK)

Code Green Apparel (PK)

AMC Entertainment

Asia Broadband (PK)

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions